XML 23 R9.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:      
Net income attributable to Ebix, Inc. $ 64,645 $ 68,188 $ 92,377
Net income (loss) attributable to Ebix, Inc. (2,017) (1,249) (3,550)
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 18,531 15,178 13,738
(Benefit) provision for doubtful accounts 1,433 (2,334) 1,749
(Benefit) provision for deferred taxes, net of acquisitions and effects of currency translation (17,972) (11,104) 5,114
Amortization of right-of-use assets 3,557 4,294 6,100
Amortization of capitalized software development costs 2,983 3,317 3,367
Share-based compensation 3,875 5,360 4,792
Reduction of acquisition earn-out contingent liability 0 0 (3,105)
Cash paid for acquisition earn-out 0 0 (6,453)
Intangible asset impairment 0 0 6,168
Changes in assets and liabilities, net of effects from acquisitions:      
Accounts receivable (15,049) (10,866) 3,258
Receivables from service providers (2,871) 3,359 20,896
Payables to service agents 5,003 1,015 (6,915)
Other assets (8,409) (17,305) (10,487)
Accounts payable and accrued expenses 21,183 18,545 (14,569)
Accrued payroll and related benefits (56) (143) 2,100
Lease liabilities (3,460) (3,951) (5,700)
Reserve for potential uncertain income tax return positions 0 (2,071) 0
Contract liabilities 6,722 694 3,680
Other liabilities (531) (1,456) (12,204)
Net cash provided by operating activities 77,567 69,471 100,356
Cash flows from investing activities:      
Investments in acquired businesses, net of cash acquired 0 0 (14,276)
Maturities (purchases) of unrestricted marketable securities, net   8,567  
Maturities (purchases) of unrestricted marketable securities, net 968   20,964
Capitalized software development costs (7,051) (5,700) (4,229)
Capital expenditures (14,476) (7,465) (5,337)
Net cash used in investing activities (22,495) (4,598) (44,806)
Cash flows from financing activities:      
Proceeds from revolving line of credit, net 10,500 0 1,364
Principal payments of term loan obligation (23,464) (42,594) (20,711)
Working capital facilities (1,765) (10,913) (10,927)
Proceeds (payments) of short-term debt, net 1,147 1,075  
Proceeds (payments) of short-term debt, net     (271)
Payments of finance lease obligations, net (190) (100) (210)
Proceeds from exercise of common stock options 0 0 636
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested (128) (1,402) (2,589)
Dividend payments (9,271) (9,284) (9,245)
Net cash (used in) provided by financing activities (23,171) (63,218) (41,953)
Effect of foreign exchange rates on cash and cash equivalents (21,706) (7,104) (4,753)
Net change in cash and cash equivalents, and restricted cash 10,195 (5,449) 8,844
Cash and cash equivalents, and restricted cash at the beginning of the year 114,764 120,213 111,369
Cash and cash equivalents, and restricted cash at the end of the year 124,959 114,764 120,213
Supplemental disclosures of cash flow information:      
Interest paid 33,244 30,369 29,498
Income taxes paid $ 24,201 $ 17,675 $ 21,321